Team:Tec-Monterrey/projectresults
From 2011.igem.org
(Difference between revisions)
Line 612: | Line 612: | ||
<p class="textojustif"> | <p class="textojustif"> | ||
- | All the insoluble fractions of the transformed strains have a significant amount of a protein that matches the predicted weight of our chimeric construct (100kDa), in comparison to their negative controls (insoluble fraction of wild type lysates)(Figure 1). There is also no significant visual difference between each induced strain; this suggests that any strain is a good host for our construct, letting reduce the number of strains in future research. According to Clontech’s buffer kit user manual, our protein could be trapped in the pellet (insoluble phase) because of its high molecular weight (100kD > 40kD) and because it is a membrane- bound protein that can form multiprotein complexes and as we did not use Clontech’s TALON CellThru for direct purification from crude cell lysates (unclarified cell lysates), which is the solution proposed by the user manual in order to further solubilize proteins. Unclarified cell lysates were not further processed. | + | All the insoluble fractions of the transformed strains have a significant amount of a protein that matches the predicted weight of our chimeric construct (100kDa), in comparison to their negative controls (insoluble fraction of wild type lysates)(Figure 1). There is also no significant visual difference between each induced strain; this suggests that any strain is a good host for our construct, letting reduce the number of strains in future research. According to Clontech’s buffer kit user manual, our protein could be trapped in the pellet (insoluble phase) because of its high molecular weight (100kD > 40kD) and because it is a membrane- bound protein that can form multiprotein complexes and as we did not use Clontech’s TALON CellThru for direct purification from crude cell lysates (unclarified cell lysates), which is the solution proposed by the user manual in order to further solubilize proteins. Unclarified cell lysates were not further processed. |
</p><br><br> | </p><br><br> | ||
Line 627: | Line 627: | ||
<br><br> | <br><br> | ||
- | + | <p class="textojustif"> Future research includes identification of protein membrane display by periplasm extraction, Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form and SEM (Scanning Electron Microscope). | |
+ | <br> | ||
+ | <br> | ||
<br> | <br> | ||
- | |||
<center> | <center> | ||
Line 656: | Line 657: | ||
In the cell-lysate cellulase activity assay (Figure 3) The glucose concentration in the soluble fraction of celD-estA was of 358 µM and in the Negative Control (C-) was of 323 µM.In the insoluble fraction, the glucose contentration of the celD-estA was 374 µM and in the Negative Control (C-) was of 264 µM. The difference in soluble and insoluble fractions with its negative control was 35 µM while the difference in the insoluble fraction was 110 µM. The result of the t-test was the rejection of the null hyphothesis, suggesting that the difference between them is also significant. | In the cell-lysate cellulase activity assay (Figure 3) The glucose concentration in the soluble fraction of celD-estA was of 358 µM and in the Negative Control (C-) was of 323 µM.In the insoluble fraction, the glucose contentration of the celD-estA was 374 µM and in the Negative Control (C-) was of 264 µM. The difference in soluble and insoluble fractions with its negative control was 35 µM while the difference in the insoluble fraction was 110 µM. The result of the t-test was the rejection of the null hyphothesis, suggesting that the difference between them is also significant. | ||
<br> | <br> | ||
- | + | <br> | |
<center><img src="https://static.igem.org/mediawiki/2011/f/fb/Thelsolinsol.png" alt="photo3" name="photo3" width="400" id="photo3"/></center> | <center><img src="https://static.igem.org/mediawiki/2011/f/fb/Thelsolinsol.png" alt="photo3" name="photo3" width="400" id="photo3"/></center> | ||
<br> | <br> | ||
Line 691: | Line 692: | ||
<br> | <br> | ||
- | + | <br> | |
<center> | <center> | ||
<b>2.2. OmpA+sacC Expression</b> | <b>2.2. OmpA+sacC Expression</b> |